Personal tools

MCL coexpression mm9:226: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0.00691197873106515,0,0,0.0254682189080574,0,0,0,0,0,0.00329716094707887,0,0.0194385692658993,0,0.0163762769337066,0,0,0,0.0355566442923187,0.0173948374702491,0,0,0,0.0272915817193143,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00239442116604468,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.4191363211702,0,0,0.0113669391818926,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0311452867210519,0,0.0669038710297777,0,0,0.0140742167710327,0.000757748910863145,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0169989595124911,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0.00691197873106515,0,0,0.0254682189080574,0,0,0,0,0,0.00329716094707887,0,0.0194385692658993,0,0.0163762769337066,0,0,0,0.0355566442923187,0.0173948374702491,0,0,0,0.0272915817193143,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00239442116604468,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.4191363211702,0,0,0.0113669391818926,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0311452867210519,0,0.0669038710297777,0,0,0.0140742167710327,0.000757748910863145,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0169989595124911,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|gostat_on_MCL_coexpression=GO:0048319;axial mesoderm morphogenesis;0.024058502285053;21423!GO:0046022;positive regulation of transcription from RNA polymerase II promoter, mitotic;0.024058502285053;21423!GO:0046021;regulation of transcription from RNA polymerase II promoter, mitotic;0.024058502285053;21423!GO:0045896;regulation of transcription, mitotic;0.024058502285053;21423!GO:0045897;positive regulation of transcription, mitotic;0.024058502285053;21423!GO:0043034;costamere;0.0300607723093566;11465!GO:0048318;axial mesoderm development;0.0300607723093566;21423!GO:0008595;determination of anterior/posterior axis, embryo;0.0300607723093566;21423!GO:0000578;embryonic axis specification;0.0300607723093566;21423!GO:0007351;tripartite regional subdivision;0.0300607723093566;21423!GO:0007350;blastoderm segmentation;0.0327890781787929;21423!GO:0048863;stem cell differentiation;0.0400645629037455;21423!GO:0045214;sarcomere organization;0.0462156796374634;11465!GO:0009948;anterior/posterior axis specification;0.0471995502937702;21423!GO:0008013;beta-catenin binding;0.0494508628401405;21423!GO:0030239;myofibril assembly;0.0494508628401405;11465!GO:0055002;striated muscle cell development;0.0494508628401405;11465!
|gostat_on_MCL_coexpression=GO:0048319;axial mesoderm morphogenesis;0.024058502285053;21423!GO:0046022;positive regulation of transcription from RNA polymerase II promoter, mitotic;0.024058502285053;21423!GO:0046021;regulation of transcription from RNA polymerase II promoter, mitotic;0.024058502285053;21423!GO:0045896;regulation of transcription, mitotic;0.024058502285053;21423!GO:0045897;positive regulation of transcription, mitotic;0.024058502285053;21423!GO:0043034;costamere;0.0300607723093566;11465!GO:0048318;axial mesoderm development;0.0300607723093566;21423!GO:0008595;determination of anterior/posterior axis, embryo;0.0300607723093566;21423!GO:0000578;embryonic axis specification;0.0300607723093566;21423!GO:0007351;tripartite regional subdivision;0.0300607723093566;21423!GO:0007350;blastoderm segmentation;0.0327890781787929;21423!GO:0048863;stem cell differentiation;0.0400645629037455;21423!GO:0045214;sarcomere organization;0.0462156796374634;11465!GO:0009948;anterior/posterior axis specification;0.0471995502937702;21423!GO:0008013;beta-catenin binding;0.0494508628401405;21423!GO:0030239;myofibril assembly;0.0494508628401405;11465!GO:0055002;striated muscle cell development;0.0494508628401405;11465!
|ontology_enrichment_celltype=CL:0000553!8.95e-09!6;CL:0000556!8.95e-09!6
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001962!2.02e-12!2;UBERON:0001961!2.02e-12!2;UBERON:0001744!2.02e-12!2;UBERON:0001155!2.61e-12!2;UBERON:0000059!2.61e-12!2;UBERON:0000160!1.10e-10!31;UBERON:0002465!1.42e-08!3;UBERON:0001153!2.75e-07!1;UBERON:0001045!2.75e-07!1;UBERON:0003199!6.93e-07!1;UBERON:0005409!9.73e-07!47
}}
}}

Revision as of 18:10, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:72664273..72664275,+p1@ENSMUST00000171003
Mm9::chr11:120209809..120209822,-p2@Actg1
p2@Gm12715
Mm9::chr11:6315833..6315870,+p1@Ppia
Mm9::chr11:69485809..69485834,-p1@Eif4a1
Mm9::chr11:96787494..96787502,+p@chr11:96787494..96787502
+
Mm9::chr12:115461536..115461545,-p1@ENSMUST00000103477
Mm9::chr13:98530587..98530588,-p2@Gm10260
Mm9::chr14:46011354..46011362,+p@chr14:46011354..46011362
+
Mm9::chr14:46703699..46703701,+p1@Gm1821
Mm9::chr14:48343717..48343719,-p@chr14:48343717..48343719
-
Mm9::chr14:93595014..93595015,-p@chr14:93595014..93595015
-
Mm9::chr15:36155970..36155974,+p@chr15:36155970..36155974
+
Mm9::chr15:38167654..38167656,+p@chr15:38167654..38167656
+
Mm9::chr15:98764869..98764875,-p3@Gm5620
p3@Tuba1b
Mm9::chr16:17222378..17222389,+p@chr16:17222378..17222389
+
Mm9::chr17:74429612..74429635,-p@chr17:74429612..74429635
-
Mm9::chr17:82188702..82188707,-p@chr17:82188702..82188707
-
Mm9::chr18:44716456..44716461,+p@chr18:44716456..44716461
+
Mm9::chr19:28938256..28938257,-p1@ENSMUST00000161562
Mm9::chr19:8035658..8035660,-p@chr19:8035658..8035660
-
Mm9::chr1:193615281..193615282,-p@chr1:193615281..193615282
-
Mm9::chr1:57035338..57035355,-p@chr1:57035338..57035355
-
Mm9::chr1:57035378..57035388,-p@chr1:57035378..57035388
-
Mm9::chr1:60957704..60957705,+p1@ENSMUST00000121555
Mm9::chr1:85008653..85008660,+p1@ENSMUST00000076377
Mm9::chr2:62236000..62236005,+p@chr2:62236000..62236005
+
Mm9::chr3:127395464..127395466,-p1@ENSMUST00000159343
Mm9::chr3:132429535..132429538,+p@chr3:132429535..132429538
+
Mm9::chr3:87454882..87454885,+p@chr3:87454882..87454885
+
Mm9::chr4:145167237..145167239,-p1@ENSMUST00000117838
Mm9::chr4:82849680..82849681,-p@chr4:82849680..82849681
-
Mm9::chr6:70009225..70009230,-p1@ENSMUST00000103376
Mm9::chr6:70167443..70167446,-p1@ENSMUST00000103384
Mm9::chr6:72580544..72580553,-p12@Tcf7l1
Mm9::chr6:75248132..75248139,-p@chr6:75248132..75248139
-
Mm9::chr7:26262601..26262613,-p1@Ceacam1
Mm9::chr8:109097361..109097362,-p1@Gm10073
p2@Gm11942
Mm9::chrX:77149697..77149702,+p@chrX:77149697..77149702
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0048319axial mesoderm morphogenesis0.024058502285053
GO:0046022positive regulation of transcription from RNA polymerase II promoter, mitotic0.024058502285053
GO:0046021regulation of transcription from RNA polymerase II promoter, mitotic0.024058502285053
GO:0045896regulation of transcription, mitotic0.024058502285053
GO:0045897positive regulation of transcription, mitotic0.024058502285053
GO:0043034costamere0.0300607723093566
GO:0048318axial mesoderm development0.0300607723093566
GO:0008595determination of anterior/posterior axis, embryo0.0300607723093566
GO:0000578embryonic axis specification0.0300607723093566
GO:0007351tripartite regional subdivision0.0300607723093566
GO:0007350blastoderm segmentation0.0327890781787929
GO:0048863stem cell differentiation0.0400645629037455
GO:0045214sarcomere organization0.0462156796374634
GO:0009948anterior/posterior axis specification0.0471995502937702
GO:0008013beta-catenin binding0.0494508628401405
GO:0030239myofibril assembly0.0494508628401405
GO:0055002striated muscle cell development0.0494508628401405



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Cell Type
Ontology termp-valuen
megakaryocyte progenitor cell8.95e-096
megakaryocyte8.95e-096

Uber Anatomy
Ontology termp-valuen
gut-associated lymphoid tissue2.02e-122
mucosa-associated lymphoid tissue2.02e-122
lymphoid tissue2.02e-122
colon2.61e-122
large intestine2.61e-122
intestine1.10e-1031
lymphoid system1.42e-083
caecum2.75e-071
midgut2.75e-071
egg chamber6.93e-071
gastrointestinal system9.73e-0747


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:226&oldid=2154466"